Arno Therapeutics, Inc. announced that it has appointed Randy H. Thurman as Vice Chairman of the company's Board of Directors. Along with Arno's Chairman Dr. Arie Belldegrun, Mr. Thurman, who joined the Board in January 2013, will serve on the executive committee and work with the Company's leadership team to focus on the development of Arno's oncology pipeline, business development strategies and other key operational initiatives. Mr. Thurman brings extensive experience to his new role.

Since 2008, Mr. Thurman has served as a senior advisor and operating executive in private equity with a focus on the life sciences. He was previously founder, President and CEO of VIASYS Healthcare Inc. and was Chairman and CEO of Corning Life Sciences, which spun off both Quest Diagnostics Inc. and Covance Inc. Earlier in his career, Mr. Thurman was President of Rhone-Poulenc Rorer Pharmaceuticals Inc. and Rorer Pharmaceuticals Inc. Mr. Thurman is currently Executive Chairman of Presbia PLC and a director of Allscripts Inc.